Table 2. Biochemical parameters in HIV-infected patients, stratified according to CD4 cell count, compared with control subjects.
Parameters | HIV-Controls | HIV+ | Patients | (Cell/µL) | P |
≥500 | 200–499 | <200 | |||
(A1) | (B2) | (C3) | |||
N = 134 | N = 15 | N = 78 | N = 58 | ||
TC (g/l) | 1,96±0,54 | 1,18±0,55 | 1,07±0,38 | 0,97±0,36 | 0.0001 |
LDLC (g/l) | 0, 67±0, 46 | 0,29±0,21 | 0,50±0,42 | 0,37±0,26 | 0.0001 |
HDLC (mg/dl) | 105, 51±28, 10 | 46,91±25,22 | 46,51±21,56 | 45,27±26,45 | 0.0001 |
TAA (mM) | 0, 63±0, 17 | 0,27±0,26 | 0,17±0,14 | 0,13±0,13 | 0.0001 |
MDA (µM) | 0, 20±0, 07 | 0,39±0,10 | 0,41±0,11 | 0,42±0,10 | 0.0001 |
LPI | 0, 34±0, 14 | 17,53±32,83 | 30,83±96,87 | 31,41±90,51 | 0.0001 |
Every value is the mean ± standard deviation. P value: statistically significant difference between each clinical category and HIV-controls group for each biochemical marker mean value. (A1), (B2), (C3): Clinical categories.